Can BPC-157 peptides be used for gut health
Its about making better decisions for the patients in front of you
The April 2025 FDA safety alert on compounded topical finasteride is the most important recent development
National Law Review (Polsinelli PC) was explicit on April 22, 2026: removing a Category 2 bulk drug substance does not, on its own, authorize use of that substance in compounding or bring it within FDAs interim enforcement discretion policy for substances in Category 1. Even Category 1 substances are only under enforcement discretion, which is short of full authorization
We solicited comment on our proposed revision to 180.50(b)(2)(ii)(C) to require hospitals to calculate and encode the count of allowed amounts used to calculate the median, 10th percentile, and 90th percentile allowed amounts, as well as on our proposal that hospitals encode this data element with the actual number of allowed amounts used within the EDI 835 ERA transaction data
Peptides described here are solely for use in structured scientific study by authorized individuals